Inorevia – Trademark Portfolio

Entity Type: 99

Inorevia holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MAGELIA. The owner is based in Paris.

29 rue du Faubourg Saint-Jacques

Paris 75014 , FR

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MAGELIA
MAGELIA
Registered 2022

Trademark Classifications

Inorevia's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Inorevia have?

Inorevia has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Inorevia file in?

Inorevia files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Inorevia's most well-known trademarks?

Inorevia's registered trademark portfolio includes well-known marks such as MAGELIA. These are among 1 currently registered trademark in the portfolio.

What is Inorevia's trademark registration success rate?

Inorevia has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.